SUBSCRIBE TO OUR FREE NEWSLETTER
Daily news & progressive opinion—funded by the people, not the corporations—delivered straight to your inbox.
5
#000000
#FFFFFF
To donate by check, phone, or other method, see our More Ways to Give page.
Daily news & progressive opinion—funded by the people, not the corporations—delivered straight to your inbox.
A report released Wednesday by a key Democratic senator details how President Donald Trump's "economic policies are making life unaffordable for millions of American small businesses, their workers, and their customers."
Since Trump returned to power last year, "America's 36 million small businesses and their workers have faced increased costs for everything from healthcare to electricity, groceries, childcare, housing, and other everyday necessities," notes Pain Street, the new report from Sen. Ed Markey (D-Mass.), ranking member of the Senate Committee on Small Business and Entrepreneurship.
The report highlights Republicans' so-called One Big Beautiful Bill Act (OBBBA), which slashed various benefits for US families, and their refusal to extend Affordable Care Act (ACA) subsidies that helped over 20 million Americans afford health insurance.
The OBBBA's $1 trillion Medicaid cut "is devastating for small businesses," the document declares, noting that 630,000 owners and more than 7.5 million workers at such companies rely on the federal program for healthcare coverage. Additionally, over 10 million owners and employees relied on the ACA tax credits that expired at the end of last year.
The publication also points to the president's attacks on clean energy and support for the planet-wrecking fossil fuel industry that helped him secure a second term. It says that "household electric bills have increased by 11.5%, and commercial electric bills have increased by 9%," stressing that such costs have climbed "more than three times faster than the overall rate of inflation."

The report also spotlights the "whiplash and cost of Trump's reckless tariffs," emphasizing that while the president often claims foreign countries are paying for his import taxes, "analysis by the Kiel Institute for the World Economy found that 96% of Trump's tariffs are being paid by American importers and consumers."
Specifically, since last March, US small businesses have shelled out more than $63.1 billion because of Trump tariffs. California—the world's fifth-largest economy—leads the state-by-state breakdown, at $14.3 billion, followed by Texas ($7 billion), New York ($4.9 billion), New Jersey ($4.1 billion), Georgia ($3.9 billion), Florida ($3.6 billion), Illinois ($2.3 billion), Ohio ($2 billion), Michigan ($1.7 billion), and South Carolina ($1.6 billion).

The president also claims that his tariffs are spurring a "manufacturing renaissance," but "approximately 98% of manufacturers in the United States employ fewer than 500 workers, with 75% of manufacturers employing fewer than 20," the report states. "US manufacturing shrank for the 10th consecutive month in December, and US factories have shed 72,000 jobs since Trump's 'liberation day' in April."
Adding to the evidence of Trump's negative impact, the Bureau of Labor Statistics announced Wednesday that across all sectors, US employers added just 181,000 jobs last year, far below its initial estimate of 584,000, and the country's economy has more than a million fewer jobs than previously reported.

Markey's staff further found that "soaring rents have left a record 22.6 million renters—approximately 50% of all renters in the US—struggling to afford their rent," 70% of families said last year that raising children is too expensive, and Trump's deportation agenda is estimated to reduce the number of immigrant and US-born workers by more than 5 million.
"Small businesses don't have Mar-a-Lago memberships, golden gifts, or ballroom invitations granting them special exemptions from Trump’s reckless economic policies, including his tariff taxes," Markey said in a statement announcing the report.
"Since Inauguration Day, Trump has made life more expensive for Americans—driving up costs on everything from healthcare, electricity, and groceries to childcare and housing—all while giving tax cuts to CEO billionaires and currying favors with big business," he continued. "As Trump's affordability crisis wreaks havoc on Main Street, we must fight back to protect small businesses, working families, and communities in Massachusetts and across the country."
As part of that fight, Markey has tried to pass multiple pieces of legislation that would exempt small businesses from Trump's tariffs, but both chambers of Congress remain narrowly controlled by the president's Republican Party.
"It is not good enough just to be critical of Trump and his destructive policies. We must bring forth a positive vision that will improve the lives of ordinary Americans."
While taking aim at the oligarchs behind companies including Walmart and the Washington Post this week, Sen. Bernie Sanders also laid out his vision for how to not only "reverse America's decline" under President Donald Trump, but also "create an economy that works for working people and not just billionaires, a vibrant democracy, and a foreign policy based on international law."
In a Guardian op-ed on Thursday, Sanders (I-Vt.) addressed issues ranging from healthcare and housing to nutrition, schooling, and transportation, pointing out that "85 million Americans are uninsured or underinsured, our life expectancy is lower than most wealthy nations, and we have a massive shortage" in health professionals.
The median home price has soared above $400,000, and over 20 million US households spend more than half of their incomes on housing. The senator noted that "as a result of corporate agriculture and the greed of the food and beverage industry, many of our kids are addicted to ultra-processed foods, and we have the highest rate of obesity and diabetes of any major country on Earth."
The United States also "ranks well behind its peers in overall educational attainment, our childcare system is broken, and millions of our young people are unable to afford a college education," wrote Sanders, a leader in the Senate Democratic Caucus who twice sought the party's presidential nomination. "Our public transportation and rail systems lag far behind most other developed countries, and millions of people spend hours a day in traffic jams."
"The decline we are seeing in our country is not just in economics. Our political system is corrupt, dominated by an extremely greedy billionaire class that is able to buy and sell politicians," he stressed. "Even more troubling, our country is rapidly descending into authoritarianism under an unstable, narcissistic leader who wants more and more power for himself."
"Trump is usurping the powers of Congress, attacking the courts, intimidating the media, threatening universities, and prosecuting and arresting his political opponents," Sanders flagged. He also renewed criticism of "Trump's domestic army," US Immigration and Customs Enforcement, for "acting in outrageous and unconstitutional ways," from Maine to Minnesota, where federal agents have recently killed two citizens.
At this difficult moment in American history, we must be honest with ourselves:Our nation, once the envy of the world, is now in profound decline. For the sake of our children and future generations, we must reverse course.
[image or embed]
— Senator Bernie Sanders (@sanders.senate.gov) February 5, 2026 at 12:42 PM
Sanders' response to the chaos and fear of Trump's second term is to advocate for "building a national grassroots movement that fights for the needs of the American working class," which he said can be done "by bringing people together—Black, white, Latino, Asian, gay and straight—around an agenda that takes on the greed of the oligarchs and is based on the foundation of economic, social, racial, and environmental justice."
Detailing his key policy priorities, the senator wrote:
Sanders isn't alone in arguing that "it is not good enough just to be critical of Trump and his destructive policies. We must bring forth a positive vision that will improve the lives of ordinary Americans." That that was also a lesson from democratic socialist New York City Mayor Zohran Mamdani's campaign, which the senator said "has given us the roadmap."
"Starting at just 1% in the polls, Mamdani had the guts to take on the Democratic establishment, the Republican, establishment, and the oligarchs. And he won by organizing a grassroots campaign of more than 90,000 volunteers knocking on doors behind a strong progressive agenda," wrote Sanders, who campaigned for and swore in the city's new mayor.
Mamdani made headlines on Thursday for his Nation piece endorsing Democratic New York Gov. Kathy Hochul's reelection campaign. The mayor wrote that although he and Hochul have "real differences, particularly when it comes to taxation of the wealthiest, at a moment defined by profound income inequality," they also delivered a "historic win together," in the form of a universal childcare program for the city.
"At its best, the Democratic Party has been a big tent not because it avoids conflict but because it channels conflict toward progress," Mamdani added. "A party united not by conformity but by a commitment to structural change—and to the work required to achieve it."
"When Big Pharma gets richer off the back of a grandmother struggling to pay for cancer medication, the system is broken."
Led by Senate Finance Committee Chair Ron Wyden, four Democratic senators on Wednesday outlined plans to reduce the costs of prescription drugs after President Donald Trump claimed he would do so—only to allow Big Pharma companies to delay negotiating lower prices and secure "zero commitments" from top executives on making lifesaving medications more affordable for millions of Americans.
“There is no greater fraud than Donald J. Trump when it comes to lower drug prices,” Wyden (D-Ore.) said. “Our doors are wide open to anybody who wants to take the bold next step forward on lowering drug costs for Americans."
Along with a "flash report" on Trump's "broken promises" regarding his pledge to bring drug prices down “to levels nobody ever thought was possible," Wyden sent a Dear Colleague letter to Democratic senators regarding his committee's plans to follow through with lowering costs.
"Finance Committee minority staff will dedicate substantial time and effort this year to developing the next generation of healthcare solutions that lower costs for American families," Wyden wrote. "These solutions will rein in Big Pharma’s outrageous price increases, lower costs for consumers, guarantee predictability for patients, and reduce wasteful government spending that pads the profits of big corporations. Alongside the co-signers of this letter, I invite you to be a part of this bold vision."
The letter, co-signed by Sens. Catherine Cortez Masto (D-Nev.), Peter Welch (D-Vt.), and Ruben Gallego (D-Ariz.), notes that "the only concrete drug pricing policy Trump enacted within the past year was a price hike for the biggest blockbuster cancer drugs on Earth, giving an $8.8 billion windfall to the pharmaceutical industry."
In contrast, the senators wrote, the Senate Finance Committee will develop policies to incorporate international pricing models into the Medicare drug price negotiation framework, including by allowing Health and Human Services Secretary Robert F. Kennedy Jr. to consider international prices as a factor or penalize drugmakers when pricing for US customers exceeds international benchmarks.
“Democrats are determined to bring prices down, and we’re willing to work with anyone to find concrete ways to do it."
The committee will also work to end Republican "blockbuster drug bailouts from negotiation," like the ones included in the One Big Beautiful Bill Act that shielded several high-priced drugs—including the cancer drug Keytruda—from Medicare price negotiations.
"The Republican budget bill contained a nearly $9 billion sweetheart deal that benefits the biggest drug companies by delaying or exempting some lifesaving medications from negotiation," reads the Democrats' flash report.
Gallego said that "when Big Pharma gets richer off the back of a grandmother struggling to pay for cancer medication, the system is broken."
"That’s what this is all about: Big Pharma execs sitting in their fancy corner offices profiting off of sick, working-class Americans,” the senator said. “We are not going to accept an America where millions of families live in fear of getting sick and needing to fill a prescription. We are going to fight and fight hard for a healthcare system that does what Donald Trump never did: actually lower costs for working families.”
The lawmakers emphasized that even if manufacturers are forced to lower drug prices, patients are not currently guaranteed to directly benefit, because as much as 45% of the $5.4 trillion the US spends on healthcare annually is "absorbed by middlemen such as insurers, pharmacy benefit managers (PBMs), and drug distributors."
"Healthcare middlemen profit when drug costs are high because they make money off of drug margin or payments that are linked to the price of a drug, ripping off patients who pay more than they should. Medicare Part D and the patients it serves should stop footing the bill for inflated drug prices and instead pay for drugs in a more transparent manner that reduces middleman margin," wrote the senators.
The Finance Committee will develop policies to eliminate abuses in the prescription drug supply chain including "egregious drug price markups," and to ensure that patient cost-sharing on drugs more closely aligns with the costs to plans and PBMs.
Finally, the Democrats said they would work to fix the "unmitigated disaster" that Trump and Kennedy have been "for innovation and drug development," as the administration has proposed slashing the National Institutes of Health budget by 40% and has cut off access to treatment for an estimated 74,000 patients who were enrolled in NIH clinical trials.
The Finance Committee, they said, plans to create new incentives for innovation and drug development, including through the tax code.
In their flash report, the Democrats wrote that while failing to force Big Pharma to the negotiating table to save money for Americans, Trump "has been parading Big Pharma executives through the White House, claiming to be cutting cost-saving deals with these corporations."
"One look under the hood reveals the truth: Trump is giving them a pass on tariffs, while receiving zero commitments about how they will lower costs for taxpayers and patients," they wrote. "Donald Trump is getting fleeced by Big Pharma CEOs, and Americans are going to foot the bill."
Welch said that the president "loves to talk a big game and make promises to working families about lowering prescription drug prices. But in reality, his administration is handling this like a PR problem: They’ve got to keep moving and talking about it, but then do nothing to really address the crisis."
“Democrats are determined to bring prices down, and we’re willing to work with anyone to find concrete ways to do it," said Welch. "We’re going to lower healthcare costs and ensure everyone can access affordable, lifesaving, and pain-relieving medication.”